Infliximab Biosimilar for Intravenous Drip Infusion 100 mg " Pfizer " Drug Use Investigation (Psoriasis)

Conditions:   Psoriasis Vulgaris;   Psoriasis Arthropathica;   Pustular Psoriasis;   Erythrodermic Psoriasis Intervention:   Drug: Infliximab [infliximab biosimilar 3] Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials